Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin PK in Critically Ill Patients on CVVHDF
NCT01212432Phase 2Unknown
- Sponsor
- University of Zurich
- Start
- Dec 2009
- Primary completion
- Mar 2010
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daptomycin in Gram-positive bacterial infection, sponsored by University of Zurich. Status: unknown.
02
Drugs
daptomycin
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on NCT01212432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01212432.